NasdaqGM:PRCTMedical Equipment
PROCEPT BioRobotics Resets Commercial Model To Pursue Higher Quality Growth
PROCEPT BioRobotics (NasdaqGM:PRCT) has overhauled its commercial model, implementing a major realignment of its sales organization and pricing strategy.
The company has removed bulk purchase discounts and created a dedicated team focused on driving greater procedural adoption.
These changes come alongside significant procedure growth and a reset in financial guidance, marking a key shift in how the company pursues profitability and market expansion.
PROCEPT BioRobotics focuses on robotic...